Mark B Powers Selected Research

Yohimbine (Yocon)

1/2018	Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl.
6/2014	Yohimbine enhancement of exposure therapy for social anxiety disorder: a randomized controlled trial.
11/2013	Enhancing exposure therapy for PTSD with yohimbine HCL: protocol for a double-blind, randomized controlled study implementing subjective and objective measures of treatment outcome.
1/2012	Does yohimbine hydrochloride facilitate fear extinction in virtual reality treatment of fear of flying? A randomized placebo-controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark B Powers Research Topics

Disease

12	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 06/2021 - 09/2003
5	Wounds and Injuries (Trauma) 06/2021 - 10/2010
5	Anxiety Disorders (Anxiety Disorder) 01/2015 - 02/2013
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 04/2015 - 05/2013
1	COVID-19 10/2022
1	Substance-Related Disorders (Drug Abuse) 12/2019
1	Prescription Drug Overuse 12/2019
1	Syndrome (Syndromes) 12/2019
1	Obesity 06/2016
1	Metabolic Diseases (Metabolic Disease) 06/2016
1	Alcoholism (Alcohol Abuse) 01/2016
1	Social Phobia 06/2014
1	Phobic Disorders (Phobia) 06/2013
1	Mood Disorders (Mood Disorder) 04/2013
1	Aerophobia 01/2012

Drug/Important Bio-Agent (IBA)

4	Yohimbine (Yocon)IBA 01/2018 - 01/2012
2	Nicotine FDA Link 11/2018 - 01/2016
2	Pharmaceutical PreparationsIBA 01/2018 - 09/2017
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 04/2015 - 05/2013
2	Cycloserine (Seromycin)FDA Link 06/2013 - 02/2013
1	COVID-19 VaccinesIBA 10/2022
1	VaccinesIBA 10/2022
1	Illicit Drugs (Recreational Drugs)IBA 12/2019
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2019
1	Hydrocortisone (Cortisol)FDA LinkGeneric 06/2016
1	Naltrexone (ReVia)FDA LinkGeneric 01/2016
1	Risperidone (Risperdal Consta)FDA LinkGeneric 04/2015
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2015
1	D 53IBA 06/2014
1	alpha-2 Adrenergic ReceptorsIBA 11/2013
1	Anti-Anxiety Agents (Anxiolytics)IBA 04/2013
1	Therapeutic UsesIBA 04/2013
1	Dopamine (Intropin)FDA LinkGeneric 09/2003

Therapy/Procedure

6	Therapeutics 06/2021 - 10/2010
1	Critical Care (Surgical Intensive Care) 01/2020
1	Surgical Amputation (Amputations) 12/2019
1	Patient Readmission 09/2018
1	Aftercare (After-Treatment) 10/2010